移植前肝脏灌注液中聚糖模式与原发性无功能相关
该前瞻性研究分析了比利时2011年10月1日至2017年4月30日肝移植患者的灌注液,发现单一聚糖NGA2F在发生原发性无功能(PNF)的4例供肝灌注液中显著升高,并以100%准确率识别PNF,在验证集中得到验证。
要点
- 灌注液中NGA2F水平在发生PNF的供肝中显著升高。
- NGA2F以100%准确率识别PNF患者。
- NGA2F是唯一与PNF相关的因素(P < .0001)。
核心结论
- 肝移植患者灌注液中NGA2F水平与PNF发生相关,准确率100%,并在独立队列中验证。
研究设计与样本
- 前瞻性研究纳入连续肝移植患者,推导集66例来自1个中心,验证集56例来自2个中心,比利时,2011年10月1日至2017年4月30日。
- 供肝均采用冷静态保存,移植前经肝静脉冲洗收集灌注液。
- 从灌注液中分离蛋白连接N-聚糖,采用基于多毛细管电泳的ABI3130测序仪分析。
主要发现
- 发生PNF的4例患者供肝灌注液中NGA2F相对丰度显著高于未发生PNF者。
- NGA2F水平识别PNF患者的准确率为100%。
- 多因素分析中,NGA2F是推导集和验证集中唯一与PNF相关的因素(P < .0001)。
关键数值与推荐
- PNF定义为移植物无功能且排除肝动脉血栓或急性细胞排斥等其他原因后需紧急再移植。
临床怎么用
- 作者认为该生物标志物或可用于移植前评估移植物,尤其考虑高风险器官时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Primary nonfunction (PNF) is a rare complication after liver transplantation that requires urgent retransplantation. PNF is associated with livers from extended criteria donors. Clinical and biochemical factors have not been identified that reliably associate with graft function after liver transplantation. Serum patterns of N-glycans associate with changes in the liver. We analyzed perfusate from grafted liver to identify protein glycosylation patterns associated with PNF. METHODS: We performed a prospective study of consecutive patients who underwent liver transplantation (66 patients, from 1 center, in the derivation set, and 56 patients, from 2 centers, in the validation set) in Belgium, from October 1, 2011, through April 30, 2017. All donor grafts were transported using cold static storage, and perfusate samples were collected from the livers by flushing of hepatic veins before transplantation. Protein-linked N-glycans were isolated from perfusate samples and analyzed with a multicapillary electrophoresis-based ABI3130 sequencer. We compared glycan patterns between patients with vs without PNF of transplanted livers. PNF was defined as the need for urgent retransplantation when a graft had no evidence of function, after exclusion of other causes, such as hepatic artery thrombosis or acute cellular rejection. RESULTS: The relative abundance of a single glycan, agalacto core-alpha-1,6-fucosylated biantennary glycan (NGA2F) was significantly increased in perfusate of livers given to 4 patients who developed PNF after liver transplantation compared with livers given to patients who did not develop PNF. Level of NGA2F identified patients with PNF with 100% accuracy. This glycomarker was the only factor associated with PNF in multivariate analysis in the derivation and the validation sets (P < .0001). CONCLUSIONS: In an analysis of patients who underwent liver transplantation, we associated graft perfusate level of glycan NGA2F present on perfusate proteins with development of PNF with 100% accuracy, and validated this finding in a separate cohort of patients. This biomarker might be used to assess grafts before transplantation, especially when high-risk organs are under consideration.
引用
- Verhelst X, Geerts A, Jochmans I, et al. Glycome Patterns of Perfusate in Livers Before Transplantation Associate With Primary Nonfunction. Gastroenterology. 2018. PMID: 29309776. doi:10.1053/j.gastro.2017.12.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。